CD163 and cancer: While the TAMs function to antagonize the anti-tumor effect of oncolytic viruses in GBMs, the CD68+ population may clear the apoptotic cancer cells in response to oncolytic treatment, whereas the CD163+ population may promote the growth of the remaining uninfected cancer cells [37,38].